EXTRACTS OF ASTER KORAIENSIS, AND PHARMACEUTICAL COMPOSITION AND FUNCTIONAL FOOD COMPRISING THE SAME
    3.
    发明公开
    EXTRACTS OF ASTER KORAIENSIS, AND PHARMACEUTICAL COMPOSITION AND FUNCTIONAL FOOD COMPRISING THE SAME 有权
    FROM ASTER红松提取物和含有药物组合物和功能性食品

    公开(公告)号:EP2131850A1

    公开(公告)日:2009-12-16

    申请号:EP08723329.2

    申请日:2008-03-07

    IPC分类号: A61K36/28

    摘要: Disclosed herein are a leaf and stem extract of Aster koraiensis, a root extract of Aster koraiensis, a flower extract of Aster koraiensis, a pharmaceutical composition for the prevention or treatment of diabetic complications, a health functional food for the improvement of diabetic complications, and a pharmaceutical composition and health functional food for the prevention or delay of aging, in which each of the compositions and the foods contain, as an active ingredient, at least one of said Aster koraiensis extracts. Each of the extracts is obtained by drying and finely cutting each of the leaf and stem part, root and flower of Aster koraiensis, extracting the cut plant with alcohol or aqueous alcohol solution, filtering the extracted solution and concentrating the filtrate under reduced pressure. Also disclosed are a pharmaceutical composition for the prevention or treatment of diabetic complications, a health functional food for the improvement of diabetic complications, and a pharmaceutical composition and health functional food for the prevention or delay of aging, which contain, as an active ingredient, at least one of fractions obtained by fractionating each of said Aster koraiensis extracts in the order of hexane, ethyl acetate, n-butanol and water fractions. The leaf and stem extract of Aster koraiensis, the root extract of Aster koraiensis and the flower extract of Aster koraiensis have the effect of inhibiting the production of advanced glycation endproducts (AGEs), the causes of diabetic complications, and effectively inhibit aldose redductase (AR) activity. Thus, the disclosed extracts will be highly useful for the prevention or treatment of diabetic complications and the prevention of aging.

    COMPOSITION AND FUNCTIONAL FOOD USING POLYGONUM CUSPIDATUM BUTANOL EXTRACT OR ETHYL ACETATE EXTRACT FOR TREATING AND PREVENTING OBESITY
    4.
    发明公开
    COMPOSITION AND FUNCTIONAL FOOD USING POLYGONUM CUSPIDATUM BUTANOL EXTRACT OR ETHYL ACETATE EXTRACT FOR TREATING AND PREVENTING OBESITY 有权
    组合物和功能性食物或丁醇的乙酸乙酯萃取物用于治疗虎杖OFF和预防肥胖的

    公开(公告)号:EP2520307A1

    公开(公告)日:2012-11-07

    申请号:EP09852833.4

    申请日:2009-12-29

    IPC分类号: A61K36/70 A61P3/04 A23L1/307

    CPC分类号: A61K36/704 A23L33/105

    摘要: The present invention relates to the obesity-curative or obesity-preventive effect of a Polygonum cuspidatum butanol fraction and a Polygonum cuspidatum ethylacetate fraction, and more particularly, to a pharmaceutical composition and a functional food for treating obesity, the pharmaceutical composition and the functional food comprising a Polygonum cuspidatum butanol fraction (POCU-1b) and an ethylacetate fraction as active ingredients, wherein the Polygonum cuspidatum butanol fraction and the ethylacetate fraction inhibit effectively the activity of pancreatic lipase, an important enzyme involving in fat absorption in a living body, and have excellent inhibitory effect on fat absorption in the short term fat absorption-inhibitory animal experiments using lipid emulsions.

    摘要翻译: 本发明涉及一种虎杖丁醇馏分的肥胖治疗或肥胖症的预防效果和虎杖乙酸乙酯组分,并且更具体地,涉及一种药物组合物和用于治疗肥胖症的功能性食品,药物组合物和功能性食品 包括虎杖丁醇馏分(迫促-1b)和在乙酸乙酯级分作为有效成分,所述worin虎杖丁醇馏分和乙酸乙酯组分有效抑制在活体中脂肪的吸收涉及重要的酶胰脂肪酶的活性,并 有在使用脂质乳剂短期内脂肪吸收抑制动物实验上脂肪吸收优异的抑制效果。